Oncotype-dx DCIS score

Aliases
  • Oncotype DX Breast DCIS Score
  • Oncotype-dx DCIS score
Description
From www.oncotypeiq.com: The Oncotype DX Breast DCIS Score test looks at the tumor biology to find out how likely your cancer is to return. Before the Breast DCIS Score test, doctors only had measurements (such as margin width, tumor size, and tumor grade) to estimate how likely a patient’s cancer was to return. The Breast DCIS Score provides information about your tumor that’s not available from these pathological measures. The Breast DCIS Score is a genomic test — it looks at the activity of tumor genes. Specifically, the Breast DCIS Score tests a group of cancer-related genes in your tumor tissue. These genes can provide information about how your tumor might behave in the future, including how likely it is to grow and spread.
Attributes
QA State
Under Review
Type
Proteomic
HGNC Name
Certifications
  • None
QA State for Breast
Under Review

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.